MENU
COR
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

COR stock forecast, quote, news & analysis

Cencora is one of three leading domestic pharmaceutical wholesalers... Show more

COR
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for COR with price predictions
Sep 23, 2026

COR in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 17, 2026

COR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 21 of 31 cases where COR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 68%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 25 of 42 cases where COR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 60%.

Following a +1.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where COR advanced for three days, in 239 of 386 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

The Aroon Indicator entered an Uptrend today. In 222 of 348 cases where COR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on COR as a result. In 40 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 49%.

The Moving Average Convergence Divergence Histogram (MACD) for COR turned negative on September 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 26 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 50%.

COR moved below its 50-day moving average on September 17, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 41%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 14 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 27 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. COR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 72 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (19.685) is normal, around the industry mean (2.563). P/E Ratio (23.343) is within average values for comparable stocks, (39.285). Projected Growth (PEG Ratio) (0.658) is also within normal values, averaging (2.034). Dividend Yield (0.008) settles around the average of (0.004) among similar stocks. P/S Ratio (0.187) is also within normal values, averaging (4.260).

A.I.Advisor
published Dividends

COR paid dividends on August 31, 2026

Cencora COR Stock Dividends
А dividend of $0.60 per share was paid with a record date of August 31, 2026, and an ex-dividend date of August 14, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 22.6B. The market cap for tickers in the group ranges from 44.8K to 103.91B. MCK holds the highest valuation in this group at 103.91B. The lowest valued company is COCM at 44.8K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was 4%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was -17%. COSM experienced the highest price growth at 49%, while ACH experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was 83%. For the same stocks of the Industry, the average monthly volume growth was 126% and the average quarterly volume growth was 159%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 58
Price Growth Rating: 61
SMR Rating: 87
Profit Risk Rating: 72
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
COR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a real estate investment trust

Industry MedicalDistributors

Industry
Real Estate Investment Trusts
Address
1 West First Avenue
Phone
+1 610 727-7000
Employees
51000
Web
https://www.cencora.com
COR in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 17, 2026